世界のエステティック注射剤市場予測 2023年-2029年

【英語タイトル】Global Aesthetics Injectable Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC11451)・商品コード:LP23DC11451
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:122
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のエステティック注射剤市場」は、過去の販売実績から2022年の世界のエステティック注射剤の総販売量を検討し、2023年から2029年の予測されるエステティック注射剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のエステティック注射剤の市場規模を掲載し、XXX百万米ドル規模の世界のエステティック注射剤市場の詳細な分析を提供します。本インサイトレポートは、世界のエステティック注射剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のエステティック注射剤市場における各社の独自のポジションをより深く理解するために、エステティック注射剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のエステティック注射剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。エステティック注射剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。エステティック注射剤の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。エステティック注射剤のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

エステティック注射剤の世界主要メーカーとしては、Luminera、 ALLERGAN、 Anika Therapeutics, Inc.,、 Medytox、 Merz Pharma、 Nestlé Skin Health、 Galderma Laboratories, L.P、 Sinclair Pharma、 Suneva Medical、 Teoxane、 Advanced Dermatology and Cosmetic Surgery、 Bausch Health、 Sanofi、 Ipsen Pharma、 Integra LifeSciences Corporation、 FibroGen, Inc.、 Medical Devices Business Services, Inc.,、 DR. Korman、 Shanghai Fosun Pharmaceutical(Group)Co., Ltd.、 Cynosure LLCなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のエステティック注射剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではエステティック注射剤市場をセグメンテーションし、種類別 (シワ改善剤、皮膚充填剤)、用途別 (フェイスライン矯正、口唇増大術、フェイスリフト、ニキビ跡治療、脂肪萎縮治療、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:シワ改善剤、皮膚充填剤

・用途別区分:フェイスライン矯正、口唇増大術、フェイスリフト、ニキビ跡治療、脂肪萎縮治療、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のエステティック注射剤市場の10年間の市場状況・展望は?
・世界および地域別に見たエステティック注射剤市場成長の要因は何か?
・エステティック注射剤の市場機会はエンドマーケットの規模によってどのように変化するのか?
・エステティック注射剤のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:エステティック注射剤の年間販売量2018-2029、地域別現状・将来分析
・エステティック注射剤の種類別セグメント:シワ改善剤、皮膚充填剤
・エステティック注射剤の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・エステティック注射剤の用途別セグメント:フェイスライン矯正、口唇増大術、フェイスリフト、ニキビ跡治療、脂肪萎縮治療、その他
・エステティック注射剤の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のエステティック注射剤市場
・企業別のグローバルエステティック注射剤市場データ:2018-2023年の年間販売量、市場シェア
・企業別のエステティック注射剤の年間売上:2018-2023年の売上、市場シェア
・企業別のエステティック注射剤販売価格
・主要企業のエステティック注射剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

エステティック注射剤の地域別レビュー
・地域別のエステティック注射剤市場規模2018-2023:年間販売量、売上
・主要国別のエステティック注射剤市場規模2018-2023:年間販売量、売上
・南北アメリカのエステティック注射剤販売の成長
・アジア太平洋のエステティック注射剤販売の成長
・ヨーロッパのエステティック注射剤販売の成長
・中東・アフリカのエステティック注射剤販売の成長

南北アメリカ市場
・南北アメリカの国別のエステティック注射剤販売量、売上(2018-2023)
・南北アメリカのエステティック注射剤の種類別販売量
・南北アメリカのエステティック注射剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のエステティック注射剤販売量、売上(2018-2023)
・アジア太平洋のエステティック注射剤の種類別販売量
・アジア太平洋のエステティック注射剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のエステティック注射剤販売量、売上(2018-2023)
・ヨーロッパのエステティック注射剤の種類別販売量
・ヨーロッパのエステティック注射剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のエステティック注射剤販売量、売上(2018-2023)
・中東・アフリカのエステティック注射剤の種類別販売量
・中東・アフリカのエステティック注射剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・エステティック注射剤の製造コスト構造分析
・エステティック注射剤の製造プロセス分析
・エステティック注射剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・エステティック注射剤の主要なグローバル販売業者
・エステティック注射剤の主要なグローバル顧客

地域別のエステティック注射剤市場予測レビュー
・地域別のエステティック注射剤市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・エステティック注射剤の種類別市場規模予測
・エステティック注射剤の用途別市場規模予測

主要企業分析
Luminera、 ALLERGAN、 Anika Therapeutics, Inc.,、 Medytox、 Merz Pharma、 Nestlé Skin Health、 Galderma Laboratories, L.P、 Sinclair Pharma、 Suneva Medical、 Teoxane、 Advanced Dermatology and Cosmetic Surgery、 Bausch Health、 Sanofi、 Ipsen Pharma、 Integra LifeSciences Corporation、 FibroGen, Inc.、 Medical Devices Business Services, Inc.,、 DR. Korman、 Shanghai Fosun Pharmaceutical(Group)Co., Ltd.、 Cynosure LLC
・企業情報
・エステティック注射剤製品
・エステティック注射剤販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Aesthetics Injectable market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Aesthetics Injectable is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Aesthetics Injectable is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Aesthetics Injectable is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Aesthetics Injectable players cover Luminera, ALLERGAN, Anika Therapeutics, Inc.,, Medytox, Merz Pharma, Nestlé Skin Health, Galderma Laboratories, L.P, Sinclair Pharma and Suneva Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Aesthetic injectables, often known as dermal fillers, are medications that help with bioengineering or face rejuvenation. As people become older, their facial skin loses subcutaneous fat & draws closer to their facial muscles, causing more visible smile lines and wrinkles. As a result of this, the facial skin stretches, resulting to volume loss. These concerns can be addressed with aesthetic injectables or dermal fillers, which aid in the treatment of early signs of ageing or add benefit to a facial rejuvenation process.
LPI (LP Information)’ newest research report, the “Aesthetics Injectable Industry Forecast” looks at past sales and reviews total world Aesthetics Injectable sales in 2022, providing a comprehensive analysis by region and market sector of projected Aesthetics Injectable sales for 2023 through 2029. With Aesthetics Injectable sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aesthetics Injectable industry.
This Insight Report provides a comprehensive analysis of the global Aesthetics Injectable landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aesthetics Injectable portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aesthetics Injectable market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aesthetics Injectable and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aesthetics Injectable.
This report presents a comprehensive overview, market shares, and growth opportunities of Aesthetics Injectable market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Wrinkle Relaxers
Dermal Fillers
Segmentation by application
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Luminera
ALLERGAN
Anika Therapeutics, Inc.,
Medytox
Merz Pharma
Nestlé Skin Health
Galderma Laboratories, L.P
Sinclair Pharma
Suneva Medical
Teoxane
Advanced Dermatology and Cosmetic Surgery
Bausch Health
Sanofi
Ipsen Pharma
Integra LifeSciences Corporation
FibroGen, Inc.
Medical Devices Business Services, Inc.,
DR. Korman
Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
Cynosure LLC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aesthetics Injectable market?
What factors are driving Aesthetics Injectable market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aesthetics Injectable market opportunities vary by end market size?
How does Aesthetics Injectable break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aesthetics Injectable Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Aesthetics Injectable by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Aesthetics Injectable by Country/Region, 2018, 2022 & 2029
2.2 Aesthetics Injectable Segment by Type
2.2.1 Wrinkle Relaxers
2.2.2 Dermal Fillers
2.3 Aesthetics Injectable Sales by Type
2.3.1 Global Aesthetics Injectable Sales Market Share by Type (2018-2023)
2.3.2 Global Aesthetics Injectable Revenue and Market Share by Type (2018-2023)
2.3.3 Global Aesthetics Injectable Sale Price by Type (2018-2023)
2.4 Aesthetics Injectable Segment by Application
2.4.1 Facial Line Correction
2.4.2 Lip Augmentation
2.4.3 Face Lift
2.4.4 Acne Scar Treatment
2.4.5 Lipoatrophy Treatment
2.4.6 Other
2.5 Aesthetics Injectable Sales by Application
2.5.1 Global Aesthetics Injectable Sale Market Share by Application (2018-2023)
2.5.2 Global Aesthetics Injectable Revenue and Market Share by Application (2018-2023)
2.5.3 Global Aesthetics Injectable Sale Price by Application (2018-2023)
3 Global Aesthetics Injectable by Company
3.1 Global Aesthetics Injectable Breakdown Data by Company
3.1.1 Global Aesthetics Injectable Annual Sales by Company (2018-2023)
3.1.2 Global Aesthetics Injectable Sales Market Share by Company (2018-2023)
3.2 Global Aesthetics Injectable Annual Revenue by Company (2018-2023)
3.2.1 Global Aesthetics Injectable Revenue by Company (2018-2023)
3.2.2 Global Aesthetics Injectable Revenue Market Share by Company (2018-2023)
3.3 Global Aesthetics Injectable Sale Price by Company
3.4 Key Manufacturers Aesthetics Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aesthetics Injectable Product Location Distribution
3.4.2 Players Aesthetics Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aesthetics Injectable by Geographic Region
4.1 World Historic Aesthetics Injectable Market Size by Geographic Region (2018-2023)
4.1.1 Global Aesthetics Injectable Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Aesthetics Injectable Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aesthetics Injectable Market Size by Country/Region (2018-2023)
4.2.1 Global Aesthetics Injectable Annual Sales by Country/Region (2018-2023)
4.2.2 Global Aesthetics Injectable Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aesthetics Injectable Sales Growth
4.4 APAC Aesthetics Injectable Sales Growth
4.5 Europe Aesthetics Injectable Sales Growth
4.6 Middle East & Africa Aesthetics Injectable Sales Growth
5 Americas
5.1 Americas Aesthetics Injectable Sales by Country
5.1.1 Americas Aesthetics Injectable Sales by Country (2018-2023)
5.1.2 Americas Aesthetics Injectable Revenue by Country (2018-2023)
5.2 Americas Aesthetics Injectable Sales by Type
5.3 Americas Aesthetics Injectable Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aesthetics Injectable Sales by Region
6.1.1 APAC Aesthetics Injectable Sales by Region (2018-2023)
6.1.2 APAC Aesthetics Injectable Revenue by Region (2018-2023)
6.2 APAC Aesthetics Injectable Sales by Type
6.3 APAC Aesthetics Injectable Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aesthetics Injectable by Country
7.1.1 Europe Aesthetics Injectable Sales by Country (2018-2023)
7.1.2 Europe Aesthetics Injectable Revenue by Country (2018-2023)
7.2 Europe Aesthetics Injectable Sales by Type
7.3 Europe Aesthetics Injectable Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aesthetics Injectable by Country
8.1.1 Middle East & Africa Aesthetics Injectable Sales by Country (2018-2023)
8.1.2 Middle East & Africa Aesthetics Injectable Revenue by Country (2018-2023)
8.2 Middle East & Africa Aesthetics Injectable Sales by Type
8.3 Middle East & Africa Aesthetics Injectable Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aesthetics Injectable
10.3 Manufacturing Process Analysis of Aesthetics Injectable
10.4 Industry Chain Structure of Aesthetics Injectable
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aesthetics Injectable Distributors
11.3 Aesthetics Injectable Customer
12 World Forecast Review for Aesthetics Injectable by Geographic Region
12.1 Global Aesthetics Injectable Market Size Forecast by Region
12.1.1 Global Aesthetics Injectable Forecast by Region (2024-2029)
12.1.2 Global Aesthetics Injectable Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aesthetics Injectable Forecast by Type
12.7 Global Aesthetics Injectable Forecast by Application
13 Key Players Analysis
13.1 Luminera
13.1.1 Luminera Company Information
13.1.2 Luminera Aesthetics Injectable Product Portfolios and Specifications
13.1.3 Luminera Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Luminera Main Business Overview
13.1.5 Luminera Latest Developments
13.2 ALLERGAN
13.2.1 ALLERGAN Company Information
13.2.2 ALLERGAN Aesthetics Injectable Product Portfolios and Specifications
13.2.3 ALLERGAN Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ALLERGAN Main Business Overview
13.2.5 ALLERGAN Latest Developments
13.3 Anika Therapeutics, Inc.,
13.3.1 Anika Therapeutics, Inc., Company Information
13.3.2 Anika Therapeutics, Inc., Aesthetics Injectable Product Portfolios and Specifications
13.3.3 Anika Therapeutics, Inc., Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Anika Therapeutics, Inc., Main Business Overview
13.3.5 Anika Therapeutics, Inc., Latest Developments
13.4 Medytox
13.4.1 Medytox Company Information
13.4.2 Medytox Aesthetics Injectable Product Portfolios and Specifications
13.4.3 Medytox Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Medytox Main Business Overview
13.4.5 Medytox Latest Developments
13.5 Merz Pharma
13.5.1 Merz Pharma Company Information
13.5.2 Merz Pharma Aesthetics Injectable Product Portfolios and Specifications
13.5.3 Merz Pharma Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merz Pharma Main Business Overview
13.5.5 Merz Pharma Latest Developments
13.6 Nestlé Skin Health
13.6.1 Nestlé Skin Health Company Information
13.6.2 Nestlé Skin Health Aesthetics Injectable Product Portfolios and Specifications
13.6.3 Nestlé Skin Health Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nestlé Skin Health Main Business Overview
13.6.5 Nestlé Skin Health Latest Developments
13.7 Galderma Laboratories, L.P
13.7.1 Galderma Laboratories, L.P Company Information
13.7.2 Galderma Laboratories, L.P Aesthetics Injectable Product Portfolios and Specifications
13.7.3 Galderma Laboratories, L.P Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Galderma Laboratories, L.P Main Business Overview
13.7.5 Galderma Laboratories, L.P Latest Developments
13.8 Sinclair Pharma
13.8.1 Sinclair Pharma Company Information
13.8.2 Sinclair Pharma Aesthetics Injectable Product Portfolios and Specifications
13.8.3 Sinclair Pharma Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sinclair Pharma Main Business Overview
13.8.5 Sinclair Pharma Latest Developments
13.9 Suneva Medical
13.9.1 Suneva Medical Company Information
13.9.2 Suneva Medical Aesthetics Injectable Product Portfolios and Specifications
13.9.3 Suneva Medical Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Suneva Medical Main Business Overview
13.9.5 Suneva Medical Latest Developments
13.10 Teoxane
13.10.1 Teoxane Company Information
13.10.2 Teoxane Aesthetics Injectable Product Portfolios and Specifications
13.10.3 Teoxane Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teoxane Main Business Overview
13.10.5 Teoxane Latest Developments
13.11 Advanced Dermatology and Cosmetic Surgery
13.11.1 Advanced Dermatology and Cosmetic Surgery Company Information
13.11.2 Advanced Dermatology and Cosmetic Surgery Aesthetics Injectable Product Portfolios and Specifications
13.11.3 Advanced Dermatology and Cosmetic Surgery Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Advanced Dermatology and Cosmetic Surgery Main Business Overview
13.11.5 Advanced Dermatology and Cosmetic Surgery Latest Developments
13.12 Bausch Health
13.12.1 Bausch Health Company Information
13.12.2 Bausch Health Aesthetics Injectable Product Portfolios and Specifications
13.12.3 Bausch Health Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Bausch Health Main Business Overview
13.12.5 Bausch Health Latest Developments
13.13 Sanofi
13.13.1 Sanofi Company Information
13.13.2 Sanofi Aesthetics Injectable Product Portfolios and Specifications
13.13.3 Sanofi Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sanofi Main Business Overview
13.13.5 Sanofi Latest Developments
13.14 Ipsen Pharma
13.14.1 Ipsen Pharma Company Information
13.14.2 Ipsen Pharma Aesthetics Injectable Product Portfolios and Specifications
13.14.3 Ipsen Pharma Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ipsen Pharma Main Business Overview
13.14.5 Ipsen Pharma Latest Developments
13.15 Integra LifeSciences Corporation
13.15.1 Integra LifeSciences Corporation Company Information
13.15.2 Integra LifeSciences Corporation Aesthetics Injectable Product Portfolios and Specifications
13.15.3 Integra LifeSciences Corporation Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Integra LifeSciences Corporation Main Business Overview
13.15.5 Integra LifeSciences Corporation Latest Developments
13.16 FibroGen, Inc.
13.16.1 FibroGen, Inc. Company Information
13.16.2 FibroGen, Inc. Aesthetics Injectable Product Portfolios and Specifications
13.16.3 FibroGen, Inc. Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 FibroGen, Inc. Main Business Overview
13.16.5 FibroGen, Inc. Latest Developments
13.17 Medical Devices Business Services, Inc.,
13.17.1 Medical Devices Business Services, Inc., Company Information
13.17.2 Medical Devices Business Services, Inc., Aesthetics Injectable Product Portfolios and Specifications
13.17.3 Medical Devices Business Services, Inc., Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Medical Devices Business Services, Inc., Main Business Overview
13.17.5 Medical Devices Business Services, Inc., Latest Developments
13.18 DR. Korman
13.18.1 DR. Korman Company Information
13.18.2 DR. Korman Aesthetics Injectable Product Portfolios and Specifications
13.18.3 DR. Korman Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 DR. Korman Main Business Overview
13.18.5 DR. Korman Latest Developments
13.19 Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
13.19.1 Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Company Information
13.19.2 Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Aesthetics Injectable Product Portfolios and Specifications
13.19.3 Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Main Business Overview
13.19.5 Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Latest Developments
13.20 Cynosure LLC
13.20.1 Cynosure LLC Company Information
13.20.2 Cynosure LLC Aesthetics Injectable Product Portfolios and Specifications
13.20.3 Cynosure LLC Aesthetics Injectable Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Cynosure LLC Main Business Overview
13.20.5 Cynosure LLC Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Aesthetics Injectable Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Aesthetics Injectable Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Wrinkle Relaxers
Table 4. Major Players of Dermal Fillers
Table 5. Global Aesthetics Injectable Sales by Type (2018-2023) & (K Units)
Table 6. Global Aesthetics Injectable Sales Market Share by Type (2018-2023)
Table 7. Global Aesthetics Injectable Revenue by Type (2018-2023) & ($ million)
Table 8. Global Aesthetics Injectable Revenue Market Share by Type (2018-2023)
Table 9. Global Aesthetics Injectable Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Aesthetics Injectable Sales by Application (2018-2023) & (K Units)
Table 11. Global Aesthetics Injectable Sales Market Share by Application (2018-2023)
Table 12. Global Aesthetics Injectable Revenue by Application (2018-2023)
Table 13. Global Aesthetics Injectable Revenue Market Share by Application (2018-2023)
Table 14. Global Aesthetics Injectable Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Aesthetics Injectable Sales by Company (2018-2023) & (K Units)
Table 16. Global Aesthetics Injectable Sales Market Share by Company (2018-2023)
Table 17. Global Aesthetics Injectable Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Aesthetics Injectable Revenue Market Share by Company (2018-2023)
Table 19. Global Aesthetics Injectable Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Aesthetics Injectable Producing Area Distribution and Sales Area
Table 21. Players Aesthetics Injectable Products Offered
Table 22. Aesthetics Injectable Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Aesthetics Injectable Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Aesthetics Injectable Sales Market Share Geographic Region (2018-2023)
Table 27. Global Aesthetics Injectable Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Aesthetics Injectable Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Aesthetics Injectable Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Aesthetics Injectable Sales Market Share by Country/Region (2018-2023)
Table 31. Global Aesthetics Injectable Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Aesthetics Injectable Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Aesthetics Injectable Sales by Country (2018-2023) & (K Units)
Table 34. Americas Aesthetics Injectable Sales Market Share by Country (2018-2023)
Table 35. Americas Aesthetics Injectable Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Aesthetics Injectable Revenue Market Share by Country (2018-2023)
Table 37. Americas Aesthetics Injectable Sales by Type (2018-2023) & (K Units)
Table 38. Americas Aesthetics Injectable Sales by Application (2018-2023) & (K Units)
Table 39. APAC Aesthetics Injectable Sales by Region (2018-2023) & (K Units)
Table 40. APAC Aesthetics Injectable Sales Market Share by Region (2018-2023)
Table 41. APAC Aesthetics Injectable Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Aesthetics Injectable Revenue Market Share by Region (2018-2023)
Table 43. APAC Aesthetics Injectable Sales by Type (2018-2023) & (K Units)
Table 44. APAC Aesthetics Injectable Sales by Application (2018-2023) & (K Units)
Table 45. Europe Aesthetics Injectable Sales by Country (2018-2023) & (K Units)
Table 46. Europe Aesthetics Injectable Sales Market Share by Country (2018-2023)
Table 47. Europe Aesthetics Injectable Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Aesthetics Injectable Revenue Market Share by Country (2018-2023)
Table 49. Europe Aesthetics Injectable Sales by Type (2018-2023) & (K Units)
Table 50. Europe Aesthetics Injectable Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Aesthetics Injectable Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Aesthetics Injectable Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Aesthetics Injectable Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Aesthetics Injectable Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Aesthetics Injectable Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Aesthetics Injectable Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Aesthetics Injectable
Table 58. Key Market Challenges & Risks of Aesthetics Injectable
Table 59. Key Industry Trends of Aesthetics Injectable
Table 60. Aesthetics Injectable Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Aesthetics Injectable Distributors List
Table 63. Aesthetics Injectable Customer List
Table 64. Global Aesthetics Injectable Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Aesthetics Injectable Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Aesthetics Injectable Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Aesthetics Injectable Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Aesthetics Injectable Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Aesthetics Injectable Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Aesthetics Injectable Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Aesthetics Injectable Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Aesthetics Injectable Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Aesthetics Injectable Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Aesthetics Injectable Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Aesthetics Injectable Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Aesthetics Injectable Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Aesthetics Injectable Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Luminera Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 79. Luminera Aesthetics Injectable Product Portfolios and Specifications
Table 80. Luminera Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Luminera Main Business
Table 82. Luminera Latest Developments
Table 83. ALLERGAN Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 84. ALLERGAN Aesthetics Injectable Product Portfolios and Specifications
Table 85. ALLERGAN Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. ALLERGAN Main Business
Table 87. ALLERGAN Latest Developments
Table 88. Anika Therapeutics, Inc., Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 89. Anika Therapeutics, Inc., Aesthetics Injectable Product Portfolios and Specifications
Table 90. Anika Therapeutics, Inc., Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Anika Therapeutics, Inc., Main Business
Table 92. Anika Therapeutics, Inc., Latest Developments
Table 93. Medytox Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 94. Medytox Aesthetics Injectable Product Portfolios and Specifications
Table 95. Medytox Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Medytox Main Business
Table 97. Medytox Latest Developments
Table 98. Merz Pharma Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 99. Merz Pharma Aesthetics Injectable Product Portfolios and Specifications
Table 100. Merz Pharma Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Merz Pharma Main Business
Table 102. Merz Pharma Latest Developments
Table 103. Nestlé Skin Health Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 104. Nestlé Skin Health Aesthetics Injectable Product Portfolios and Specifications
Table 105. Nestlé Skin Health Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Nestlé Skin Health Main Business
Table 107. Nestlé Skin Health Latest Developments
Table 108. Galderma Laboratories, L.P Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 109. Galderma Laboratories, L.P Aesthetics Injectable Product Portfolios and Specifications
Table 110. Galderma Laboratories, L.P Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Galderma Laboratories, L.P Main Business
Table 112. Galderma Laboratories, L.P Latest Developments
Table 113. Sinclair Pharma Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinclair Pharma Aesthetics Injectable Product Portfolios and Specifications
Table 115. Sinclair Pharma Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sinclair Pharma Main Business
Table 117. Sinclair Pharma Latest Developments
Table 118. Suneva Medical Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 119. Suneva Medical Aesthetics Injectable Product Portfolios and Specifications
Table 120. Suneva Medical Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Suneva Medical Main Business
Table 122. Suneva Medical Latest Developments
Table 123. Teoxane Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 124. Teoxane Aesthetics Injectable Product Portfolios and Specifications
Table 125. Teoxane Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Teoxane Main Business
Table 127. Teoxane Latest Developments
Table 128. Advanced Dermatology and Cosmetic Surgery Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 129. Advanced Dermatology and Cosmetic Surgery Aesthetics Injectable Product Portfolios and Specifications
Table 130. Advanced Dermatology and Cosmetic Surgery Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Advanced Dermatology and Cosmetic Surgery Main Business
Table 132. Advanced Dermatology and Cosmetic Surgery Latest Developments
Table 133. Bausch Health Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 134. Bausch Health Aesthetics Injectable Product Portfolios and Specifications
Table 135. Bausch Health Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Bausch Health Main Business
Table 137. Bausch Health Latest Developments
Table 138. Sanofi Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 139. Sanofi Aesthetics Injectable Product Portfolios and Specifications
Table 140. Sanofi Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Sanofi Main Business
Table 142. Sanofi Latest Developments
Table 143. Ipsen Pharma Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 144. Ipsen Pharma Aesthetics Injectable Product Portfolios and Specifications
Table 145. Ipsen Pharma Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Ipsen Pharma Main Business
Table 147. Ipsen Pharma Latest Developments
Table 148. Integra LifeSciences Corporation Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 149. Integra LifeSciences Corporation Aesthetics Injectable Product Portfolios and Specifications
Table 150. Integra LifeSciences Corporation Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Integra LifeSciences Corporation Main Business
Table 152. Integra LifeSciences Corporation Latest Developments
Table 153. FibroGen, Inc. Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 154. FibroGen, Inc. Aesthetics Injectable Product Portfolios and Specifications
Table 155. FibroGen, Inc. Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. FibroGen, Inc. Main Business
Table 157. FibroGen, Inc. Latest Developments
Table 158. Medical Devices Business Services, Inc., Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 159. Medical Devices Business Services, Inc., Aesthetics Injectable Product Portfolios and Specifications
Table 160. Medical Devices Business Services, Inc., Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Medical Devices Business Services, Inc., Main Business
Table 162. Medical Devices Business Services, Inc., Latest Developments
Table 163. DR. Korman Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 164. DR. Korman Aesthetics Injectable Product Portfolios and Specifications
Table 165. DR. Korman Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. DR. Korman Main Business
Table 167. DR. Korman Latest Developments
Table 168. Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 169. Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Aesthetics Injectable Product Portfolios and Specifications
Table 170. Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Main Business
Table 172. Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Latest Developments
Table 173. Cynosure LLC Basic Information, Aesthetics Injectable Manufacturing Base, Sales Area and Its Competitors
Table 174. Cynosure LLC Aesthetics Injectable Product Portfolios and Specifications
Table 175. Cynosure LLC Aesthetics Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Cynosure LLC Main Business
Table 177. Cynosure LLC Latest Developments
List of Figures
Figure 1. Picture of Aesthetics Injectable
Figure 2. Aesthetics Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aesthetics Injectable Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Aesthetics Injectable Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Aesthetics Injectable Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Wrinkle Relaxers
Figure 10. Product Picture of Dermal Fillers
Figure 11. Global Aesthetics Injectable Sales Market Share by Type in 2022
Figure 12. Global Aesthetics Injectable Revenue Market Share by Type (2018-2023)
Figure 13. Aesthetics Injectable Consumed in Facial Line Correction
Figure 14. Global Aesthetics Injectable Market: Facial Line Correction (2018-2023) & (K Units)
Figure 15. Aesthetics Injectable Consumed in Lip Augmentation
Figure 16. Global Aesthetics Injectable Market: Lip Augmentation (2018-2023) & (K Units)
Figure 17. Aesthetics Injectable Consumed in Face Lift
Figure 18. Global Aesthetics Injectable Market: Face Lift (2018-2023) & (K Units)
Figure 19. Aesthetics Injectable Consumed in Acne Scar Treatment
Figure 20. Global Aesthetics Injectable Market: Acne Scar Treatment (2018-2023) & (K Units)
Figure 21. Aesthetics Injectable Consumed in Lipoatrophy Treatment
Figure 22. Global Aesthetics Injectable Market: Lipoatrophy Treatment (2018-2023) & (K Units)
Figure 23. Aesthetics Injectable Consumed in Other
Figure 24. Global Aesthetics Injectable Market: Other (2018-2023) & (K Units)
Figure 25. Global Aesthetics Injectable Sales Market Share by Application (2022)
Figure 26. Global Aesthetics Injectable Revenue Market Share by Application in 2022
Figure 27. Aesthetics Injectable Sales Market by Company in 2022 (K Units)
Figure 28. Global Aesthetics Injectable Sales Market Share by Company in 2022
Figure 29. Aesthetics Injectable Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Aesthetics Injectable Revenue Market Share by Company in 2022
Figure 31. Global Aesthetics Injectable Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Aesthetics Injectable Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Aesthetics Injectable Sales 2018-2023 (K Units)
Figure 34. Americas Aesthetics Injectable Revenue 2018-2023 ($ Millions)
Figure 35. APAC Aesthetics Injectable Sales 2018-2023 (K Units)
Figure 36. APAC Aesthetics Injectable Revenue 2018-2023 ($ Millions)
Figure 37. Europe Aesthetics Injectable Sales 2018-2023 (K Units)
Figure 38. Europe Aesthetics Injectable Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Aesthetics Injectable Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Aesthetics Injectable Revenue 2018-2023 ($ Millions)
Figure 41. Americas Aesthetics Injectable Sales Market Share by Country in 2022
Figure 42. Americas Aesthetics Injectable Revenue Market Share by Country in 2022
Figure 43. Americas Aesthetics Injectable Sales Market Share by Type (2018-2023)
Figure 44. Americas Aesthetics Injectable Sales Market Share by Application (2018-2023)
Figure 45. United States Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Aesthetics Injectable Sales Market Share by Region in 2022
Figure 50. APAC Aesthetics Injectable Revenue Market Share by Regions in 2022
Figure 51. APAC Aesthetics Injectable Sales Market Share by Type (2018-2023)
Figure 52. APAC Aesthetics Injectable Sales Market Share by Application (2018-2023)
Figure 53. China Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Aesthetics Injectable Sales Market Share by Country in 2022
Figure 61. Europe Aesthetics Injectable Revenue Market Share by Country in 2022
Figure 62. Europe Aesthetics Injectable Sales Market Share by Type (2018-2023)
Figure 63. Europe Aesthetics Injectable Sales Market Share by Application (2018-2023)
Figure 64. Germany Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Aesthetics Injectable Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Aesthetics Injectable Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Aesthetics Injectable Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Aesthetics Injectable Sales Market Share by Application (2018-2023)
Figure 73. Egypt Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Aesthetics Injectable Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Aesthetics Injectable in 2022
Figure 79. Manufacturing Process Analysis of Aesthetics Injectable
Figure 80. Industry Chain Structure of Aesthetics Injectable
Figure 81. Channels of Distribution
Figure 82. Global Aesthetics Injectable Sales Market Forecast by Region (2024-2029)
Figure 83. Global Aesthetics Injectable Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Aesthetics Injectable Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Aesthetics Injectable Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Aesthetics Injectable Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Aesthetics Injectable Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のエステティック注射剤市場予測 2023年-2029年] (コード:LP23DC11451)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエステティック注射剤市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆